---  
layout: startup_page  
title: "LongBio Pharma"  
id: "longbio.com"  
permalink: "/longbiopharmalongbio.com09242024/"  
website: "http://www.longbio.com/"  
funding_round: "Series B2"  
funding_amount: ""  
investors: "Qiming Venture Partners"  
about: "LongBio Pharma is a Phase III-stage biotech company developing innovative antibody and fusion protein drugs for allergies and complement-mediated diseases. They leverage a proprietary technology platform to create biologics with independent intellectual property rights, such as LP-003, a high-affinity anti-IgE antibody, and LP-005, a bi-functional anti-C3&C5 antibody. These drugs aim to offer superior efficacy and cost-effectiveness compared to existing treatments."  
markets: "Biotechnology, Pharmaceuticals, Medical"  
hq: "Suzhou, Jiangsu, China"  
founded_year: "2020"  
linkedin: ""  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/longbio-pharma"  
pitchbook: ""  

date_display: "24-Sep-2024"  
date: "2024-09-24"

# SEO Optimization  
meta_title: "LongBio Pharma - Series B2"  
meta_description: "LongBio Pharma, LongBio Pharma is a Phase III-stage biotech company developing innovative antibody and fusion protein drugs for allergies and complement-mediated dise..."  
meta_keywords: "LongBio Pharma, Biotechnology, Pharmaceuticals, Medical, Series B2 funding"  
canonical_url: "https://startup.projectstartups.com/longbiopharmalongbio.com09242024/"  
---